Skip to main content
. 2018 Mar 8;13(3):e0193491. doi: 10.1371/journal.pone.0193491

Table 2. Treatment outcomes of DRTB patients stratified by DST profiles and HIV status.

Treatment outcome HIV-negative HIV-positive p-value Overall
PDR-TB patients (N = 426) <0.001
 Cured 148 (46.5) 55 (50.9) 203 (47.6)
 Completed treatment 96 (30.2) 19 (17.6) 115 (27.0)
Success 244 (76.7) 74 (68.5) 318 (74.6)
 Died 9 (2.8) 21 (19.4) 30 (7.0)
 Failed 19 (6.0) 7 (6.5) 26 (6.1)
 Lost to follow-up 46 (14.5) 6 (5.6) 52 (12.2)
MDR-TB patients (N = 809) <0.001
 Cured 240 (40.1) 102 (48.3) 342 (42.3)
 Completed treatment 78 (13.0) 33 (15.6) 111 (13.7)
Success 318 (53.2) 135 (64.0) 453 (56.0)
 Died 56 (9.4) 40 (19.0) 96 (11.9)
 Failed 67 (11.2) 11 (5.2) 78 (9.6)
 Lost to follow-up 157 (26.2) 25 (11.8) 182 (22.5)
Overall (N = 1,369) <0.001
 Cured 413 (43.4) 221 (52.9) 634 (46.3)
 Completed treatment 175 (18.4) 63 (15.1) 238 (17.4)
Success 588 (61.8) 284 (67.9) 872 (63.7)
 Died 67 (7.0) 80 (19.1) 147 (10.7)
 Failed 87 (9.2) 19 (4.6) 106 (7.7)
 Lost to follow-up 209 (22.0) 35 (8.4) 244 (17.8)